Impairment of platelet function by growth-hormone release-inhibiting hormone

PubMed

Insights

Synthetic cyclic growth-hormone release-inhibiting hormone (G.H.-R.I.H.) infusions temporarily impaired platelet aggregation in healthy men. While G.H.-R.I.H. did not affect clotting times, caution is advised for prolonged use due to potential side effects.

Area of Science:

  • Endocrinology
  • Hematology
  • Pharmacology

Background:

  • Growth-hormone release-inhibiting hormone (G.H.-R.I.H.) is a synthetic peptide hormone.
  • Platelet aggregation plays a crucial role in hemostasis and thrombosis.
  • Previous studies suggested potential effects of G.H.-R.I.H. on platelet function in animal models.

Purpose of the Study:

  • To investigate the effects of synthetic cyclic G.H.-R.I.H. on platelet aggregation and other hemostatic parameters in healthy human subjects.
  • To assess the duration of G.H.-R.I.H.'s impact on platelet function.
  • To evaluate potential side effects associated with G.H.-R.I.H. infusion.

Main Methods:

  • Four healthy male volunteers received 6-hour infusions of synthetic cyclic G.H.-R.I.H.
  • Platelet aggregation, platelet counts, prothrombin-time, partial thromboplastin-time, fibrinogen titres, and fibrinogen-degradation products were measured.
  • In vitro incubation of G.H.-R.I.H. with blood was performed to assess direct effects on platelet aggregation.
  • Adverse events were monitored during and after the infusions.

Main Results:

  • Synthetic cyclic G.H.-R.I.H. impaired platelet aggregation in all subjects during the 6-hour infusion.
  • The anti-aggregatory effect persisted for over 24 hours in three out of four subjects.
  • No significant changes were observed in platelet counts during infusion, but a slight increase occurred 18 hours post-infusion.
  • Coagulation parameters (prothrombin-time, PTT, fibrinogen, FDPs) remained unchanged.
  • In vitro incubation did not affect platelet aggregation, suggesting an indirect mechanism.
  • Common side effects included abdominal pain, dizziness, and diarrhea in three subjects.

Conclusions:

  • Synthetic cyclic G.H.-R.I.H. significantly impairs platelet aggregation in humans, with prolonged effects.
  • G.H.-R.I.H. does not appear to affect standard coagulation tests or platelet counts acutely.
  • Caution is warranted for extended G.H.-R.I.H. use due to potential side effects and unknown long-term toxicity.
  • Further research is needed to elucidate the precise mechanism and long-term safety profile of G.H.-R.I.H.

Related Concept Videos

Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones of the Pituitary Gland01:27

Hormones of the Pituitary Gland

The small, pea-sized pituitary gland is located at the base of the brain. It is crucial in regulating various bodily functions, from growth to reproduction. The gland is divided into the anterior lobe and the posterior lobe. The secretory cell clusters in the pars distalis of the anterior pituitary lobe are controlled by hypothalamic regulators and synthesize six primary hormones.
The most abundantly secreted hormone from the anterior lobe is the growth hormone, which controls overall growth by...
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Major Hormones and Their Functions01:27

Major Hormones and Their Functions

Hormones, the biochemical messengers produced by endocrine glands, are pivotal in regulating bodily functions and maintaining homeostasis. Each hormone's balance is crucial; imbalances can lead to significant physiological disruptions. Major hormones include oxytocin, cortisol, epinephrine, estrogen, testosterone, thyroxine, growth hormone, insulin, and glucagon.
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and lactation.